Haleon plc ( HLN) - Stock Earnings
HLN Quarterly earnings
Analyst consensus estimates are available to paid members.
| Date | Earnings | Revenue |
|---|---|---|
| 2025Q2 | 1.1 billion USD | 7.5 billion USD |
| 2025Q4 | 1.1 billion USD | 7.4 billion USD |
| 2026Q2 | 1.0 billion USD | 7.5 billion USD |
| 2026Q4 Est. | — | — |
| 2027Q1 Est. | — | — |
| 2027Q2 Est. | — | — |
HLN Yearly earnings
Analyst consensus estimates are available to paid members.
| Date | Earnings | Revenue |
|---|---|---|
| 2023 | 1.3 billion USD | 14.4 billion USD |
| 2024 | 1.8 billion USD | 14.1 billion USD |
| 2025 | 2.2 billion USD | 14.8 billion USD |
| 2026 Est. | — | — |
HLN
Price: $8.80
Dividend Yield: 1.29%
Forward Dividend Yield: 1.46%
Payout Ratio: 33.17%
Dividend Per Share: 0.13 USD
Earnings Per Share: 0.49 USD
P/E Ratio: 20.31
Exchange: NYQ
Sector: Healthcare
Industry: Drug Manufacturers - Specialty & Generic
Country: United Kingdom
Volume: 23.3 million
Market Capitalization: 42.3 billion
Average Dividend Frequency: 2
Years Paying Dividends: 4